InvestorsHub Logo

Sok

04/19/15 3:47 AM

#1380 RE: KMBJN #1379

I see that we are together in this ,like we are in CTIX :)
These results are not bad at all,since there is no treatment for stroke patients in this time window .
Therapy has proved safe ,so even small improvement is huge for those patients.
They did not use stem cells in first 24 hours because they wished to avoid noise,patients who recover spontaneously.
It make sense now to make few cohorts,12-18 h, 18-24h, 24-36h,there is high probability that outcome would be better for those desperate patients.
Did you find any link to Glasgow presentation ?

JLuce888

04/19/15 10:45 AM

#1383 RE: KMBJN #1379

Great deduction. Let's see what the actual report says. Chugai may just do the phase 3 in Japan with a 12-36 hour window. They may negotiate for better terms with ATHX.